Drug InformationPharmacy FAQWhat does the term "generic" mean? Do generic medications produce the same effect that the brand name medicines do?The difference between a brand name medicine and a generic one is in the name, shape and in the price. A generic drug is u... more >> Why are generic medicines so cheap?Unlike generic drugs, a large part of the costs incurred by original manufacturers of brand name drugs are for research and development and advertising. The expense of obtaining FDA approval alone in th... more >> Pills do not look like the brand name medication. The pills have a different name printed on them. Why?As we have already mentioned that no manufacturer can take out a patent for a chemical agent. Thus generics can have the exactly same... more >> Does every brand-name drug have a generic equivalent?No. About half of all prescription drugs have generic equivalents at this time. Generics can be manufactured only after patents on brand-name drugs have expired. There will be generic ... more >> When can a generic drug be producedGeneric drugs can be legally produced for drugs where: 1) the patent has expired, 2) the generic company certifies the brand company's patents are either invalid, unenforceable or will not be infringed,... more >> That is online pharmacy?Since about the year 2000, hundreds of pharmacies have begun operating over the internet. |
special offers
Sinemet CRGeneric name: Carbidopa, Levodopa Why is Sinemet CR prescribed?Sinemet CR is a controlled-release tablet that may be given to help relieve the muscle stiffness, tremor, and weakness caused by Parkinson's disease. It may also be given to relieve Parkinson-like symptoms caused by encephalitis (brain fever), carbon monoxide poisoning, or manganese poisoning. Sinemet CR contains two drugs, carbidopa and levodopa. The drug that actually produces the anti-Parkinson's effect is levodopa. Carbidopa prevents vitamin B6 from destroying levodopa, thus allowing levodopa to work more efficiently. Parkinson's drugs such as Sinemet CR relieve the symptoms of the disease, but are not a permanent cure. Most important fact about Sinemet CRThere is also a regular, non-controlled-release form of Sinemet CR, which is called Sinemet. Over a period of hours, Sinemet CR, the controlled-release form, gives a smoother release of the drug than regular Sinemet. If you have been taking regular Sinemet, be aware that you may need a somewhat higher dosage of Sinemet CR to get the same degree of relief. Your first morning dose of Sinemet CR may take as much as an hour longer to start working than your first morning dose of regular Sinemet. How should you take Sinemet CR?Take Sinemet CR after meals, rather than before or between meals. Swallow the tablets whole without chewing or crushing them. Sinemet CR releases its ingredients slowly over a period of 4 to 6 hours. It is important to follow a careful schedule, taking your doses at the same time every day. You should not change the prescribed dosage or add another product for Parkinson's disease without first consulting your doctor. Sinemet CR works best when there is a constant amount in the blood. Try not to miss any doses, and take them at evenly spaced intervals day and night. --If you miss a dose... If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, skip the one you missed and go back to your regular schedule. Do not take 2 doses at once. --Storage instructions... Store at room temperature in a tightly closed container. What side effects may occur?Side effects from Sinemet CR cannot be anticipated. If any develop or change in intensity, inform your doctor immediately. Only your doctor can determine if it is safe for you to continue taking Sinemet CR.
Why should Sinemet CR not be prescribed?Do not take Sinemet CR if you are sensitive to or have ever had an allergic reaction to its ingredients. Sinemet CR should not be prescribed if you have a suspicious, undiagnosed mole or a history of melanoma. Special warnings about Sinemet CRMake sure your doctor knows if you have any of the following: Your doctor will monitor your liver, blood, kidney and heart functions during extended therapy with Sinemet CR. If you have been taking levodopa alone, you should stop taking levodopa for at least 12 hours before starting to take Sinemet CR. The carbidopa contained in Sinemet CR cannot eliminate side effects caused by levodopa. Since carbidopa helps levodopa reach your brain, Sinemet CR may, in fact, produce some levodopa side effects--particularly twitching, jerking, or writhing--sooner and at a lower dosage than levodopa alone or even regular Sinemet. If such involuntary movements develop while you are taking Sinemet CR, you may need a dosage reduction. Like levodopa, Sinemet CR may cause depression. Make sure your doctor knows if you have mental or emotional problems. Muscle rigidity, high temperature, rapid heartbeat or breathing, sweating, blood pressure changes, and mental changes may occur when Sinemet CR is reduced suddenly or discontinued. If you stop taking Sinemet CR abruptly, your doctor should monitor your condition carefully. You may see a red, brown, or black coloration in your saliva, urine, or sweat. This is not harmful, but may stain your clothes. Too much stomach acid can interfere with absorption of the medication. Possible food and drug interactions when taking Sinemet CRIf Sinemet CR is taken with certain other drugs, the effects of either could be increased, decreased, or altered. It is especially important to check with your doctor before combining Sinemet CR with the following: If you have been taking an MAO inhibitor such as Nardil or Parnate, you must discontinue it at least 2 weeks before starting to take Sinemet CR. A high-protein diet may impair the effectiveness of Sinement CR. Iron supplements can also reduce its effect. Special information if you are pregnant or breastfeedingIf you are pregnant or plan to become pregnant, inform your doctor immediately. Sinemet CR should be used during pregnancy only if the benefit outweighs the potential risk to the unborn child. It is not known whether Sinemet CR appears in breast milk. If Sinemet CR is essential to your health, your doctor may advise you to stop nursing your baby until your treatment with Sinemet CR is finished. Recommended dosageYour doctor will tailor your individual dosage carefully, depending on your response to previous therapy and symptoms. ADULTS For patients with mild to moderate symptoms, the initial recommended dose is 1 tablet of Sinemet CR taken 2 times a day. Starting doses should be spaced out every 4 to 8 hours and then adjusted to each patient's individual response. The usual long-term dose is 2 to 8 tablets per day, taken in divided doses every 4 to 8 hours during the waking day. Higher doses (12 or more tablets per day) and shorter intervals (less than 4 hours) have been used, but are not usually recommended. When doses of Sinemet CR are given at intervals of less than 4 hours, and/or if the divided doses are not equal, it is recommended that the smaller doses be given at the end of the day. An interval of at least 3 days between dosage adjustments is recommended. Dosage adjustment of Sinemet CR may be necessary if your doctor prescribes additional medications. CHILDREN Use of Sinemet CR in children under 18 is not recommended. OverdosageToo much Sinemet CR may cause muscle twitches, inability to open the eyes, or other symptoms of levodopa overdosage. Like other medications, Sinemet CR taken in excess can have serious consequences. If you suspect symptoms of a Sinemet CR overdose, seek medical attention immediately. Consumer Information (PDR) |
Online PharmacyOnline PharmacyOnline PharmaciesRx Generic PharmacyAggregationMeds NewsNew Drug Shows Promise for Rheumatoid ArthriitisHealthDay - FRIDAY, June 26 (HealthDay News) -- A new drug to treat rheumatoid arthritis reduces joint inflammation in severe cases while causing only mild to moderate side effects, according to a report from the first clinical trial of the drug on humans... more >>Sun, 28 Jun 2009 Prescription drugs in spotlight after Jackson death (AFP)AFP - Michael Jackson's death has lifted a veil on the sinister underbelly of fame, with associates of the pop icon hitting out at celebrity-dazzled doctors who funnel powerful narcotics to the stars... more >>Sun, 28 Jun 2009 Clinical Trials Update: June 25, 2009HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:.. more >>Fri, 26 Jun 2009 Poison control at risk in California, other statesAP - Each day, skeleton crews of doctors, nurses and pharmacists field almost 900 calls a day around California from people such as a mother whose child swallowed flea repellant and an elderly man who accidentally doubled up on his medication... more >>Thu, 25 Jun 2009 Clinical Trials Update: June 24, 2009HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com and CenterWatch:.. more >>Thu, 25 Jun 2009 New Cancer Drug Fights Tumors in Those With BRCA MutationsHealthDay - WEDNESDAY, June 24 (HealthDay News) -- A new cancer drug called olaparib worked well in an early clinical trial against breast, ovarian and prostate cancers in individuals who were genetically vulnerable to developing these malignancies... more >>Thu, 25 Jun 2009 New drug therapies raise 'ethical concerns': EU centre (AFP)AFP - Scientific advances could help fight drug addiction but new invasive treatments such as inserting electrodes into the brain raise "ethical concerns," the EU's drug monitoring centre said Wednesday... more >>Wed, 24 Jun 2009 Clinical Trials Update: June 23, 2009HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch and ClinicalConnection.com:.. more >>Wed, 24 Jun 2009 Mozambique factory to sell HIV drugs by December: officials (AFP)AFP - A Brazilian-funded factory for producing anti-retroviral drugs, the first in Mozambique, will begin selling the key HIV medication by year's end, officials said Tuesday... more >>Tue, 23 Jun 2009 Drug deals cost U.S. consumers $3.5 bln a year: FTCReuters - Consumers, insurance companies and the federal government spend an extra $3.5 billion for prescription drugs every year because brand-name companies pay generic producers to stay out of the market, the head of the U.S. Federal Trade Commission said on Tuesday... more >>Tue, 23 Jun 2009 Clinical Trials Update: June 22, 2009HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com and CenterWatch:.. more >>Tue, 23 Jun 2009 Promising Therapy for Prostate CancerHealthDay - MONDAY, June 22 (HealthDay News) -- An experimental drug therapy appears to have helped destroy allegedly inoperable prostate cancer in two patients in a clinical trial... more >>Tue, 23 Jun 2009 U.S. states say Wyeth failed to pay rebatesReuters - A coalition of 15 U.S. states filed a complaint in federal court charging that drugmaker Wyeth avoided paying millions of dollars of rebates to state Medicaid programs that had purchased its Protonix drugs, Massachusetts Attorney General Martha Coakley said on Monday... more >>Mon, 22 Jun 2009 Deal reached to cut drug costsReuters - Drug manufacturers will offer some $80 billion in prescription discounts for Medicare recipients under a deal unveiled on Saturday, which could boost President Barack Obama as he pushes to overhaul the $2.5 trillion U.S. healthcare system... more >>Sat, 20 Jun 2009 Health Tip: Life After a Heart AttackHealthDay - (HealthDay News) -- Life usually doesn't return to the way it was before a heart attack. You'll probably need to make changes to your daily way of life, including taking new medication... more >>Sat, 20 Jun 2009 Clinical Trials Update: June 19, 2009HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch and ClinicalConnection.com:.. more >>Sat, 20 Jun 2009 Program Helps 1st Graders Stay Safe Long-TermHealthDay - FRIDAY, June 19 (HealthDay News) -- A school-based prevention program begun in the early grades can reduce rates of substance abuse, violence and early sexual activity, says a U.S. study... more >>Sat, 20 Jun 2009 Make Nursing Homes More Like Home: MedicareHealthDay - FRIDAY, June 19 (HealthDay News) -- A warm, welcoming environment where residents are free to make choices regarding their care: That's the new vision of the ideal nursing home, according to a guidance issued Friday by the U.S. Centers for Medicare & Medicaid Services (CMS)... more >>Sat, 20 Jun 2009 Clinical Trials Update: June 18, 2009HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnetion.com and CenterWatch:.. more >>Fri, 19 Jun 2009 Teens of Dads Who Drink Too Much Tend to Follow SuitHealthDay - THURSDAY, June 18 (HealthDay News) -- Teen children who live with alcohol-abusing fathers are at higher risk for alcohol or drug abuse themselves, a U.S. government study released Thursday shows... more >>Fri, 19 Jun 2009 | ||
|
sinemet.net © 2007
Sinemet Consumer Information MedFacts, Cerner Multum, Micromedex, PDR and Professional Monographs (FDA) | ||||